Virtue Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-5,918
| Closed | -$515K | – | 300 |
|
|
2024
Q2 | $515K | Sell |
5,918
-1,139
| -16% | -$99.2K | 0.09% | 204 |
|
|
2024
Q1 | $636K | Buy |
+7,057
| New | +$636K | 0.11% | 170 |
|
|
2023
Q4 | – | Sell |
-7,128
| Closed | -$648K | – | 189 |
|
|
2023
Q3 | $648K | Hold |
7,128
| – | – | 0.11% | 176 |
|
|
2023
Q2 | $648K | Sell |
7,128
-276
| -4% | -$25.1K | 0.11% | 176 |
|
|
2023
Q1 | $647K | Sell |
7,404
-516
| -7% | -$45.1K | 0.11% | 162 |
|
|
2022
Q4 | $591K | Buy |
+7,920
| New | +$591K | 0.09% | 169 |
|
|
2022
Q3 | – | Sell |
-2,215
| Closed | -$211K | – | 271 |
|
|
2022
Q2 | $211K | Sell |
2,215
-23,249
| -91% | -$2.21M | 0.03% | 252 |
|
|
2022
Q1 | $3M | Sell |
25,464
-2,777
| -10% | -$327K | 0.47% | 37 |
|
|
2021
Q4 | $3.66M | Buy |
28,241
+1,612
| +6% | +$209K | 0.54% | 32 |
|
|
2021
Q3 | $3.02M | Sell |
26,629
-560
| -2% | -$63.4K | 0.53% | 33 |
|
|
2021
Q2 | $2.82M | Buy |
27,189
+1,242
| +5% | +$129K | 0.56% | 33 |
|
|
2021
Q1 | $2.17M | Buy |
25,947
+532
| +2% | +$44.5K | 0.51% | 42 |
|
|
2020
Q4 | $2.32M | Sell |
25,415
-2,657
| -9% | -$242K | 0.57% | 34 |
|
|
2020
Q3 | $2.24M | Buy |
28,072
+1,358
| +5% | +$108K | 0.55% | 43 |
|
|
2020
Q2 | $1.85M | Buy |
+26,714
| New | +$1.85M | 0.43% | 68 |
|
|
2020
Q1 | – | Sell |
-21,384
| Closed | -$1.66M | – | 88 |
|
|
2019
Q4 | $1.66M | Buy |
21,384
+5,529
| +35% | +$430K | 0.48% | 44 |
|
|
2019
Q3 | $1.16M | Buy |
15,855
+5,484
| +53% | +$402K | 0.38% | 89 |
|
|
2019
Q2 | $639K | Buy |
+10,371
| New | +$639K | 0.23% | 116 |
|
|
2018
Q2 | – | Sell |
-42
| Closed | -$2K | – | 272 |
|
|
2018
Q1 | $2K | Hold |
42
| – | – | ﹤0.01% | 484 |
|
|
2017
Q4 | $2K | Buy |
+42
| New | +$2K | ﹤0.01% | 417 |
|